Bliss GVS Pharma Ltd — Quarterly Results & Earnings

₹215.59

-3.69%

Profit Growth YoY12.32%Latest quarter

Sales Growth YoY12.27%Latest quarter

Sales CAGR 5Y3.27%5 year compound

Profit CAGR 5Y-4.53%5 year compound

📋

Quarterly Performance

YoY Profit Growth+12.32%

✅ Strong growth

YoY Sales Growth+12.27%

✅ Strong growth

OPM 5Y Average

Operating profit margin

16.95%

EPS Growth 5Y

-4.93%

Interest Coverage

Higher = safer debt servicing

15.52

ROE

8.36%

ROCE

11.72%

💡

Growth Analysis

Bliss GVS Pharma Ltd reported YoY profit growth of 12.32% and revenue growth of 12.27% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 3.27% and profits at -4.53% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Bliss GVS Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.